about
Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.Quality indicators and quality assessment in child healthTranslating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity.Management of children with sickle cell disease: a comprehensive review of the literature.Setting the agenda for quality improvement in pediatric sickle cell disease.Sickle cell disease-related pediatric medical expenditures in the U.S.Pasteurized human donor milk use among US level 3 neonatal intensive care units.
P50
Q33315119-622261F4-1266-4CA4-859B-5E15D9B88279Q33420659-47596738-514D-4AB8-878C-680D668A1568Q33871218-285E039D-F994-4672-9846-A88CD2396A5CQ34085220-F98E7D6A-6F5C-45CA-817F-591ECADA31DFQ40070757-711F6FCE-46C2-4599-B47A-B83ABDF0C0A6Q45130084-1E16CE54-C085-486C-95D0-F757815D6653Q46219811-00088213-59A2-4E1C-AB0C-6ED50527FA39
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patricia L Kavanagh
@ast
Patricia L Kavanagh
@en
Patricia L Kavanagh
@es
Patricia L Kavanagh
@nl
Patricia L Kavanagh
@sl
type
label
Patricia L Kavanagh
@ast
Patricia L Kavanagh
@en
Patricia L Kavanagh
@es
Patricia L Kavanagh
@nl
Patricia L Kavanagh
@sl
prefLabel
Patricia L Kavanagh
@ast
Patricia L Kavanagh
@en
Patricia L Kavanagh
@es
Patricia L Kavanagh
@nl
Patricia L Kavanagh
@sl
P106
P21
P31
P496
0000-0002-3312-1576